Kingspan Group plc (KRX)
Euronext Dublin · Ireland · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 95.50 |
|---|---|
| 52-week range | 62.60 – 106.60 |
| Return, 1 month / 3 months | −1.6% / +26.7% |
| Return, 1 year / 3 years | +38.5% / +55.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 47 |
| Volatility (1 year) | 37.6% |
| Worst drawdown (1 year) | -19.9% |
| Average daily value traded | 39.21M EUR |
| Dividend yield | 0.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Kingspan Group plc is an Irish building materials company based in Kingscourt, County Cavan. It makes insulation and building envelope products, including insulated panels for walls, roofs and floors, along with related boards and systems. Its customers are mainly in the construction industry, such as contractors, builders and designers, and its products are used in commercial, industrial and residential buildings across many countries. The company also supplies environmental and water management products for buildings.
The shares are listed on the Euronext Dublin in Ireland under the code KRX, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Kingspan Group plc (KRX) trades on the Euronext Dublin in Ireland. It last closed at EUR 95.50 on 27 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 7 of 21 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 38.5% and over the last three months it rose 26.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Dublin
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 70 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 13.9% | ||
| From 52-week high | -9.3% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 26.7% | ||
| 6-month return | 20.8% | ||
| 12-month return, skipping the last month | 40.7% | ||
| Stability (higher is calmer) | 43 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 37.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.9% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 39.21M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 46 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.6% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.6% |
|---|---|
| 1 month | −1.6% |
| 3 months | +26.7% |
| 6 months | +20.8% |
| 1 year | +38.5% |
| 3 years | +55.7% |
| 5 years | +3.7% |
Signals
| 50-day / 200-day average | 99.44 / 83.85 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.10 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Sep 2026 | EUR 0.2710 |
| 9 Apr 2026 | EUR 0.2920 |
| 4 Sep 2025 | EUR 0.2630 |
| 10 Apr 2025 | EUR 0.2850 |
| 5 Sep 2024 | EUR 0.2630 |
| 11 Apr 2024 | EUR 0.2660 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Dublin; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.